Skip to main content
EUPRAXIA PHARMACEUTICALS INC. logo

EUPRAXIA PHARMACEUTICALS INC. — Investor Relations & Filings

Ticker · EPRX LEI · 254900ABKL5YBZMSYH45 US Manufacturing
Open in API
Filings indexed 96 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country CA Canada
Listing US EPRX

About EUPRAXIA PHARMACEUTICALS INC.

https://eupraxiapharma.com/home/default…

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing locally delivered, extended-release therapies. Leveraging a proprietary drug delivery platform, the company aims to address unmet medical needs by providing long-lasting treatments designed to maximize efficacy and minimize systemic side effects.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 84% confidence The document is a Form 6-K, a report of a foreign private issuer filed under the Securities Exchange Act, listing enclosed exhibits (management information circular, AGM notice, form of proxy). It does not itself contain AGM materials, financial statements, or substantive financial analysis, but is a general regulatory filing. Thus it best fits the "Regulatory Filings" category (RNS).
2026-05-29 English
FORM 6-K
Regulatory Filings Classification · 92% confidence The document is a U.S. SEC Form 6-K filing by a foreign private issuer, reporting a confirmation of proxy‐related materials mailing. It does not contain financial statements, results, or substantive management discussion, but is a compliance/regulatory submission under the Securities Exchange Act. Thus, it falls under the general regulatory filings category.
2026-05-29 English
FORM 6-K
Regulatory Filings Classification · 91% confidence The document is a SEC Form 6-K filed by a foreign private issuer, referencing an attached press release (Exhibit 99.1). It is a regulatory submission under the Securities Exchange Act, not an earnings release, annual report, or other specific category. Therefore it falls under the general Regulatory Filings category (RNS).
2026-05-28 English
6-K - EUPRAXIA PHARMACEUTICALS INC. (0001581178) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, a SEC regulatory filing by a foreign private issuer that lists attached financial statements, MD&A and certifications, but does not itself present the full interim report data. It serves as a general regulatory announcement and falls under the catch-all “Regulatory Filings” category.
2026-05-12 English
6-K - EUPRAXIA PHARMACEUTICALS INC. (0001581178) (Filer)
Regulatory Filings Classification · 85% confidence The document is a Form 6-K filed by a foreign private issuer, which attaches a press release as Exhibit 99.1. It contains no substantive financial data or detailed report but simply furnishes a press release under SEC rules. It therefore falls into the fallback “Regulatory Filings” category rather than a specific report type.
2026-05-06 English
6-K - EUPRAXIA PHARMACEUTICALS INC. (0001581178) (Filer)
Regulatory Filings Classification · 85% confidence The document is a Form 6-K filing by a foreign private issuer under the Securities Exchange Act, furnishing a press release as Exhibit 99.1. It does not contain actual financial statements or detailed report content itself but merely attaches a press release. This is a general SEC regulatory submission, best classified under Regulatory Filings (RNS).
2026-05-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.